Article    Correction    Table of Contents                    Full Text of this article    PDF of this article (PDFs free after 6 months)    Figures/Tables List    Related articles in Annals  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Ernst, E.    Related Articles in PubMed    PubMed Citation    PubMed

ACADEMIA AND CLINIC

The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava

Edzard Ernst, MD, PhD, FRCP(Edin)

1 January 2002 | Volume 136 Issue 1 | Pages 42-53

Because use of herbal remedies is increasing, a risk–benefit profile of commonly used herbs is needed. This article provides a clinically oriented overview of the efficacy and safety of ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava. Wherever possible, assessments are based on systematic reviews of randomized clinical trials. Encouraging data support the efficacy of some of these popular herbal medicinal products, and the potential for doing good seems greater than that for doing harm. The published evidence suggests that ginkgo is of questionable use for memory loss and tinnitus but has some effect on dementia and intermittent claudication. St. John's wort is efficacious for mild to moderate depression, but serious concerns exist about its interactions with several conventional drugs. Well-conducted clinical trials do not support the efficacy of ginseng to treat any condition. Echinacea may be helpful in the treatment or prevention of upper respiratory tract infections, but trial data are not fully convincing. Saw palmetto has been shown in short-term trials to be efficacious in reducing the symptoms of benign prostatic hyperplasia. Kava is an efficacious short-term treatment for anxiety. None of these herbal medicines is free of adverse effects. Because the evidence is incomplete, risk–benefit assessments are not completely reliable, and much knowledge is still lacking.

Author and Article Information

From University of Exeter, Exeter, Devon, United Kingdom.

Requests for Single Reprints: Edzard Ernst, MD, PhD, FRCP(Edin), Department of Complementary Medicine, School of Sport and Health Sciences, University of Exeter, 25 Victoria Park Road, Exeter, Devon EX2 4NT, United Kingdom; e-mail, E.Ernst{at}exeter.ac.uk.

Related articles in Annals:

Letters
The Risk–Benefit Profile of Commonly Used Herbal Therapies
Sanford H. Levy

Annals 2002 137: 1008. [Full Text]  

Letters
The Risk–Benefit Profile of Commonly Used Herbal Therapies
Edzard Ernst

Annals 2002 137: 1008. [Full Text]  

Letters
Correction: The Risk–Benefit Profile of Commonly Used Herbal Therapies

Annals 2003 138: 79. [Full Text]  

This article has been cited by other articles:

				F. J. Dunne The 'Natural Health Service': natural does not mean safe Advan. Psychiatr. Treat., January 1, 2009; 15(1): 49 - 56. [Abstract] [Full Text] [PDF]

				J. Kennedy, C.-C. Wang, and C.-H. Wu Patient Disclosure about Herb and Supplement Use among Adults in the US Evid. Based Complement. Altern. Med., December 1, 2008; 5(4): 451 - 456. [Abstract] [Full Text] [PDF]

				D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Circulation, June 24, 2008; 117(25): e510 - e526. [Abstract] [Full Text] [PDF]

				D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension, June 1, 2008; 51(6): 1403 - 1419. [Abstract] [Full Text] [PDF]

				R. K. Kalwinsky Western Worms! Explication of Aspects of Health Care Behavior Among Chamorro With HIV/AIDS J Transcult Nurs, January 1, 2008; 19(1): 55 - 63. [Abstract] [PDF]

				T. L. Charrois, C. Sadler, and S. Vohra Complementary, Holistic, and Integrative Medicine: St. John's Wort Pediatr. Rev., February 1, 2007; 28(2): 69 - 72. [Full Text] [PDF]

				S. Katz, R. Harris, J. T.-Y. Lau, and A. Chau The use of gene expression analysis and proteomic databases in the development of a screening system to determine the value of natural medicinal products. Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 65 - 70. [Abstract] [Full Text] [PDF]

				D. J. Greenblatt, R. A. Leigh-Pemberton, and L. L. von Moltke In Vitro Interactions of Water-Soluble Garlic Components with Human Cytochromes P450 J. Nutr., March 1, 2006; 136(3): 806S - 809S. [Abstract] [Full Text] [PDF]

				D. J. Greenblatt, L. L. von Moltke, Y. Luo, E. S. Perloff, K. A. Horan, A. Bruce, R. C. Reynolds, J. S. Harmatz, B. Avula, I. A. Khan, et al. Ginkgo biloba Does Not Alter Clearance of Flurbiprofen, a Cytochrome P450-2C9 Substrate J. Clin. Pharmacol., February 1, 2006; 46(2): 214 - 221. [Abstract] [Full Text] [PDF]

				G. J. McDougall Jr., V. Austin-Wells, and T. Zimmerman Utility of Nutraceutical Products Marketed for Cognitive and Memory Enhancement J Holist Nurs, December 1, 2005; 23(4): 415 - 433. [Abstract] [PDF]

				K N Woodward The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products Human and Experimental Toxicology, May 1, 2005; 24(5): 219 - 233. [Abstract] [PDF]

				D. J. Greenblatt and L. L. von Moltke Interaction of Warfarin With Drugs, Natural Substances, and Foods J. Clin. Pharmacol., February 1, 2005; 45(2): 127 - 132. [Abstract] [Full Text] [PDF]

				S. Bondurant and H. C. Sox Mainstream and Alternative Medicine: Converging Paths Require Common Standards Ann Intern Med, January 18, 2005; 142(2): 149 - 150. [Full Text] [PDF]

				P. Curtis and S. Gaylord Safety Issues in the Interaction of Conventional, Complementary, and Alternative Health Care Complementary Health Practice Review, January 1, 2005; 10(1): 3 - 31. [Abstract] [PDF]

				I. Martinez-Mir, E. Rubio, F. J Morales-Olivas, and V. Palop-Larrea Transient ischemic attack secondary to hypertensive crisis related to Panax ginseng Ann. Pharmacother., November 1, 2004; 38(11): 1970 - 1970. [Full Text] [PDF]

				C.-S. Yuan, G. Wei, L. Dey, T. Karrison, L. Nahlik, S. Maleckar, K. Kasza, M. Ang-Lee, and J. Moss Brief Communication: American Ginseng Reduces Warfarin's Effect in Healthy Patients: A Randomized, Controlled Trial Ann Intern Med, July 6, 2004; 141(1): 23 - 27. [Abstract] [Full Text] [PDF]

				M. Jakkula, T. A. Boucher, U. Beyendorff, S. M. Conn, J. E. Johnson, C. J. Nolan, C. J. Peine, and J. H. Albrecht A Randomized Trial of Chinese Herbal Medicines for the Treatment of Symptomatic Hepatitis C Arch Intern Med, June 28, 2004; 164(12): 1341 - 1346. [Abstract] [Full Text] [PDF]

				A. Sparreboom, M. C. Cox, M. R. Acharya, and W. D. Figg Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents J. Clin. Oncol., June 15, 2004; 22(12): 2489 - 2503. [Abstract] [Full Text] [PDF]

				S. L. Gray, B. R. Lackey, P. L. Tate, M. B. Riley, and N. D. Camper Mycotoxins in Root Extracts of American and Asian Ginseng Bind Estrogen Receptors {alpha} and {beta} Experimental Biology and Medicine, June 1, 2004; 229(6): 560 - 568. [Abstract] [Full Text] [PDF]

				E. M. S. Sibinga, M. C. Ottolini, A. K. Duggan, and M. H. Wilson Parent-Pediatrician Communication about Complementary and Alternative Medicine Use for Children Clinical Pediatrics, May 1, 2004; 43(4): 367 - 373. [Abstract] [PDF]

				L. G. Costa, L. Steardo, and V. Cuomo Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects Pharmacol. Rev., March 1, 2004; 56(1): 103 - 147. [Abstract] [Full Text] [PDF]

				E. Mills, R. Singh, C. Ross, E. Ernst, and J. G. Ray Sale of kava extract in some health food stores Can. Med. Assoc. J., November 25, 2003; 169(11): 1158 - 1159. [Abstract] [Full Text] [PDF]

				T. G Burnakis Comment: usefulness of herbal and dietary supplement references Ann. Pharmacother., September 1, 2003; 37(9): 1346 - 1346. [Full Text] [PDF]

				Correction: The Risk-Benefit Profile of Commonly Used Herbal Therapies Ann Intern Med, January 7, 2003; 138(1): 79 - 79. [Full Text] [PDF]

				D. M. Eisenberg, M. H. Cohen, A. Hrbek, J. Grayzel, M. I. V. Rompay, and R. A. Cooper Credentialing Complementary and Alternative Medical Providers Ann Intern Med, December 17, 2002; 137(12): 965 - 973. [Abstract] [Full Text] [PDF]

				S. H. Levy The Risk-Benefit Profile of Commonly Used Herbal Therapies Ann Intern Med, December 17, 2002; 137(12): 1008 - 1008. [Full Text] [PDF]

				A. Fisher and J. E. Morley Editorial: Antiaging Medicine: The Good, the Bad, and the Ugly J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2002; 57(10): M636 - 639. [Full Text] [PDF]

				M. Markman Safety Issues in Using Complementary and Alternative Medicine J. Clin. Oncol., September 15, 2002; 20(90001): 39s - 41. [Abstract] [Full Text] [PDF]

				Additional articles abstracted in ACP Journal Club Evid. Based Med., July 1, 2002; 7(4): 99 - 99. [Full Text] [PDF]

				D. Wardell Review: evidence is incomplete on the benefits and risks of commonly used herbal medicines Evid. Based Nurs., July 1, 2002; 5(3): 80 - 80. [Full Text] [PDF]

				E. Wooltorton Herbal kava: reports of liver toxicity Can. Med. Assoc. J., March 1, 2002; 166(6): 777 - 777. [Full Text] [PDF]